PL2457576T3 - Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji - Google Patents

Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji

Info

Publication number
PL2457576T3
PL2457576T3 PL10460047T PL10460047T PL2457576T3 PL 2457576 T3 PL2457576 T3 PL 2457576T3 PL 10460047 T PL10460047 T PL 10460047T PL 10460047 T PL10460047 T PL 10460047T PL 2457576 T3 PL2457576 T3 PL 2457576T3
Authority
PL
Poland
Prior art keywords
infections
medical
treatment
metabolic syndrome
lactobacillus reuteri
Prior art date
Application number
PL10460047T
Other languages
English (en)
Inventor
Danuta Kruszewska
Original Assignee
Eurochit Danuta Kruszewska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eurochit Danuta Kruszewska filed Critical Eurochit Danuta Kruszewska
Publication of PL2457576T3 publication Critical patent/PL2457576T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
PL10460047T 2010-11-29 2010-11-29 Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji PL2457576T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10460047.3A EP2457576B1 (en) 2010-11-29 2010-11-29 Lactobacillus reuteri strain for use in the medical and veterinary prophylaxis and treatment of metabolic syndrome or infections

Publications (1)

Publication Number Publication Date
PL2457576T3 true PL2457576T3 (pl) 2021-04-06

Family

ID=43901014

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10460047T PL2457576T3 (pl) 2010-11-29 2010-11-29 Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji

Country Status (2)

Country Link
EP (1) EP2457576B1 (pl)
PL (1) PL2457576T3 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2674162A1 (en) * 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
JP2015520773A (ja) * 2012-05-29 2015-07-23 ダヌタ・クルセフスカＤａｎｕｔａＫＲＵＳＺＥＷＳＫＡ ヒトおよび動物における予防および医薬に有用であるラクトバチルス・ロイテリｄａｎ８０を含むナノ製品ならびにこれらの医薬用途
CN106460029A (zh) * 2014-06-30 2017-02-22 株式会社明治 抑制嘌呤吸收的乳酸菌及其用途
US9867857B2 (en) 2014-08-21 2018-01-16 Food Industry Research And Development Institute Acetobacter and gluconacetobacter strains and their metabolites for use in inhibiting xanthine oxidase
US9636368B2 (en) 2014-08-22 2017-05-02 Food Industry Research And Development Institute Strain of Lactobacillus rhamnosus and its metabolites for use in inhibiting xanthine oxidase and treating gout
WO2018045534A1 (zh) * 2016-09-08 2018-03-15 潍坊华英生物科技有限公司 一种增强免疫功能的静脉注射剂
CN111388509A (zh) 2019-01-03 2020-07-10 丰华生物科技股份有限公司 用于降低血中尿酸浓度的乳酸菌菌株的食品组合物以及医药组合物
TWI719691B (zh) * 2019-10-28 2021-02-21 葡萄王生技股份有限公司 羅伊氏乳桿菌（Ｌａｃｔｏｂａｃｉｌｌｕｓ ｒｅｕｔｅｒｉ）菌株ＧＫＲ１用於製備降低尿酸之組成物的用途
CN114717127B (zh) * 2021-03-31 2023-08-29 青岛蔚蓝生物股份有限公司 一株具有预防和缓解过敏性哮喘症状的罗伊氏乳杆菌及其应用
CN116585362A (zh) * 2023-06-02 2023-08-15 江西仁仁健康微生态科技有限公司 罗伊氏粘液乳杆菌hcs02-001降尿酸应用及产品

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1988008450A1 (en) 1987-05-01 1988-11-03 Birdwell Finlayson Gene therapy for metabolite disorders
RU2092183C1 (ru) 1988-05-26 1997-10-10 Ника Хелт Продактс Лимитед (Лихтенштейн) Антивирусный или антибактериальный состав и способ его употребления
EP2476747B1 (en) * 2007-11-29 2014-09-03 Meiji Co., Ltd Lactic acid bacteria having action of lowering blood uric acid level

Also Published As

Publication number Publication date
EP2457576B1 (en) 2020-07-08
EP2457576A1 (en) 2012-05-30

Similar Documents

Publication Publication Date Title
PL2457576T3 (pl) Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
ZA201304638B (en) Composition for use in the prevention and /or treatment of skin condition and skin diseases.
PL3016667T3 (pl) Probiotyczne szczepy bakteryjne do zapobiegania i leczenia chorób w jamie ustnej
IL216582A0 (en) Composition for use in decreasing the transmission of human pathogens, devices comprising the same and uses thereof
PL2996700T3 (pl) Kompozycja zawierająca bakterie kwasu mlekowego do stosowania w zapobieganiu i/lub leczeniu zakażeń i/lub stanów zapalnych dróg moczowych i/lub pęcherza moczowego
PT2667849T (pt) Composição efervescente em forma sólida para utilização em aplicações vaginais para o tratamento de infeções vaginais
PL2364712T3 (pl) Miejscowa kompozycja kosmetyczna lub farmaceutyczna zawierająca probiotyczne szczepy pałeczek bakterii kwasu mlekowego i jej stosowanie
PL2457575T3 (pl) Nowy sposób uzyskania szczepu Lactobacillus reuteri przydatnego w profilaktyce oraz w leczeniu w medycynie ludzkiej i weterynarii
IL222333A0 (en) Use of streptococcus salivarius in the treatment of chronic infections of the respiratory tract
EP2943210B8 (en) Lactobacillus fermentum me-3 for use in treating metabolic syndrome related diseases
SI2854910T1 (sl) Nivoji ceramida pri zdravljenju in preprečevanju okužb
HK1164369A1 (en) Preparation of microvesicle-sirna composition and use of the same in aids treatment
HUE042643T2 (hu) Lactobacillus reuteri ATCC PTA 6475 csontveszteség
EP2434010A4 (en) PREVENTIVE AND / OR THERAPEUTIC AGENT FOR THE METABOLIC SYNDROME
HK1193379A1 (en) Remedial composition and treatment methods
ZA201304460B (en) Novel bacterium and extracts of said bacterium and the use of same in therapy
SG11201405778WA (en) Use of amphoteric surfactants for the prevention and treatment of pathogenic vaginal biofilms in vaginal infections
HK1219690A1 (zh) 利用抗生素來治療超重和肥胖患者感染的方法
PL2374461T3 (pl) Piroksykam do profilaktycznego i terapeutycznego leczenia zakażeń opryszczką
RS55061B1 (sr) Novi derivati amino-pirolina i njihova upotreba u prevenciji i/ili lečenju metaboličkog sindroma
GB2483313B (en) Use of probiotic strain GM-080 in treating cardiac inflammation and apoptosis
HUE038120T2 (hu) Transzferrin autoimmun betegségek kezelésében és/vagy megelõzésében történõ alkalmazásra
HU1000356D0 (en) Quinoxaline derivatives and their use for the treatment of mycobacterial infections
PL2706994T3 (pl) Farmaceutyczna kompozycja miejscowa do stosowania w leczeniu i/lub profilaktyce zakażeń zmian skórnych